ethers

Results: 3229



#Item
901Drug List for “Use of High Risk Medications in the Elderly” Measure in the 2013 Quality and Resource Use Reports

Drug List for “Use of High Risk Medications in the Elderly” Measure in the 2013 Quality and Resource Use Reports

Add to Reading List

Source URL: www.cms.gov

Language: English - Date: 2014-12-08 14:13:21
902Use for Co-branded Presentations

Use for Co-branded Presentations

Add to Reading List

Source URL: kyportal.magellanmedicaid.com

Language: English - Date: 2010-11-24 09:03:36
903Microsoft Word - Vienna Agreement July Execution Copy.docx

Microsoft Word - Vienna Agreement July Execution Copy.docx

Add to Reading List

Source URL: www.medicinespatentpool.org

Language: English - Date: 2014-12-19 09:22:52
904State Fund Success Stories Compendium Tenth Edition The Association of State Underground Storage Tank Cleanup Funds

State Fund Success Stories Compendium Tenth Edition The Association of State Underground Storage Tank Cleanup Funds

Add to Reading List

Source URL: www.astswmo.org

Language: English - Date: 2014-12-29 13:29:48
905Opioid Overdose Regulations - Questions and Answers, December 3, 2014

Opioid Overdose Regulations - Questions and Answers, December 3, 2014

Add to Reading List

Source URL: www.health.ny.gov

Language: English - Date: 2014-12-15 15:04:43
906Health Partners Plans CHIP Formulary  Updated[removed]Formulary Introduction

Health Partners Plans CHIP Formulary Updated[removed]Formulary Introduction

Add to Reading List

Source URL: www.healthpartnersplans.com

Language: English - Date: 2014-12-16 14:33:41
907Developmental Exposure to a Commercial PBDE Mixture: Effects on Protein Networks in the Cerebellum and Hippocampus of Rats

Developmental Exposure to a Commercial PBDE Mixture: Effects on Protein Networks in the Cerebellum and Hippocampus of Rats

Add to Reading List

Source URL: ehp.niehs.nih.gov

Language: English - Date: 2014-12-18 11:29:58
9081  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NUCYNTA® safely and effectively. See full prescribing information for NUCYNTA®.

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NUCYNTA® safely and effectively. See full prescribing information for NUCYNTA®.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-11-18 14:16:12
909Buprenorphine Treatment  Presented by NYS OASAS Locations and Dates:

Buprenorphine Treatment Presented by NYS OASAS Locations and Dates:

Add to Reading List

Source URL: www.oasas.ny.gov

Language: English - Date: 2014-12-08 15:21:33
910Health Partners Plans Formulary      

Health Partners Plans Formulary     

Add to Reading List

Source URL: www.healthpartnersplans.com

Language: English - Date: 2014-12-16 14:32:19